Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Omontys (peginesatide) – for Treatment of Anaemia Associated with Chronic Kidney Disease

Omontys is an erythropoiesis-stimulating agent indicated for the treatment of anaemia associated with chronic kidney disease. Image courtesy of Affymax.

Go Top